期刊文献+

碳硼烷及其在核医学领域的应用研究进展 被引量:1

Research Advancements and Applications of Carboranes in Nuclear Medicinal Chemistry
下载PDF
导出
摘要 碳硼烷由于其特殊的热稳定性和化学稳定性,在超分子化学,催化剂和药物先导等多领域已成为研究热点。近几年,碳硼烷从作为传统的硼中子俘获治疗(Boron Neutron Capture Therapy,BNCT)药物拓展到临床放射性分子成像和治疗,其在核医学领域的发展呈多样化的趋势。本文在简要介绍碳硼烷的合成和性质的基础上,对其在核医学领域的应用研究进展进行综述。 Because of their uniquely high thermal and chemical stabilities, carboranes have become a subject of study with high interest in the chemistry of supramolecules, catalysts and radiopharmaceuticals. In recent years, the role of carboranes in nuclear medicinal chemistry has been diversified, from the traditional use in boron neutron capture therapy (BNCT), to the clinical applications in molecular radioimaging and therapy. This paper provides an overview of the synthesis and characterization of carboranes and their applications in nuclear medicinal chemistry, with highlights of recent key advancements in the research areas of BNCT and radioimaging.
出处 《同位素》 CAS 2011年第4期234-239,共6页 Journal of Isotopes
基金 中国工程物理研究院科学技术发展基金(2010B0301036)
关键词 碳硼烷 核医学 研究进展 carboranes nuclear medicine advanced ment
  • 相关文献

参考文献24

  • 1Hawthorne MF, Maderna A. Applications of radi- olabeled boron clusters to the diagnosis and treat- ment of cancer[J]. Chem Rev, 1999, 99:3 421- 3 434.
  • 2Larsen AS, Holbrey JD, Tham FS, et al. Desig- ning ionic liquids: imidazolium melts with inert earborane anions[J]. J Am Chem Soc, 2000, 122: 7 264-7 272.
  • 3Ivanova SM, Ivanov SV, Miller SM, et al. Mo- no-, di-, tri-, and tetracarbonyls of copper( I ), including the structures of Cu (CO)2 (1-Bn- CB11F11) and [Cu (COb ] [1-Et-CB11F11][J]. Inorg Chem, 1999, 38:3 756-3 757.
  • 4Juhasz M, Hoffmann S, Stoyanov E, et al. The strongest isolable aeid[J]. Angew Chem Int Ed, 2004, 43:5 352-5 355.
  • 5Armstrong AF, Valliant JF. The bioinorganic and medicinal chemistry of carboranes: from new drug discovery to molecular imaging and therapy[J]. Dalton Trans, 2007, 4 240-4 251.
  • 6Valliant JF, Guenther KJ, King AS, et al. The medicinal chemistry of earboranes[J]. Coordina- tion Chemistry Reviews, 2002, 232: 173-230.
  • 7Soloway AH, Tjarks W, Barnum BA, et al. The chemistry of neutron capture therapy[J]. Chem Rev, 1998, 98:1 515-1 562.
  • 8Tibbitts J, Sambol NC, Fike JR, et al. Plasma pharmaeokinetics and tissue biodistribution of bo- ron following administration of a boronated por- phyrin in dogs [J]. J Pharm Sci, 2000, 89: 469-477.
  • 9Rosenthal MA, Kavar B, Hill JS, et al. Phase I and pharmacokinetie study of photodynamie thera- py for high-grade gliomas using a novel boronated porphyrin[J]. Clin Oncol, 2001, 19: 519-524.
  • 10Dagrosa MA, Viaggi M, Rebagliati RJ, et al. Biodistribution of boron compounds in an animal model of human undifferentiated thyroid cancer for boron neutron capture therapy [J]. Mol Pharm, 20135, 2: 151-156.

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部